Clinical Trials in Villingen-Schwenningen, Germany
Locations / Villingen-Schwenningen, Germany
Delta Trials hosts 314 clinical trials conducted in Villingen-Schwenningen, Germany, making it a notable site of clinical research activity. These trials covering 276 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 29 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Villingen-Schwenningen.
314
Total Trials
276
Conditions
29
Terminated since 2020
Browse by condition (276 total)
- Diabetes mellitus, type 2 16 trialsAll Diabetes mellitus, type 2 trials
- Anemia 15 trialsAll Anemia trials
- Non-small cell lung cancer 13 trialsAll Non-small cell lung cancer trials
- Multiple myeloma 12 trialsAll Multiple myeloma trials
- Acute myeloid leukemia 11 trialsAll Acute myeloid leukemia trials
- Heart failure 10 trialsAll Heart failure trials
- Breast cancer 7 trialsAll Breast cancer trials
- Atrial fibrillation 7 trialsAll Atrial fibrillation trials
- Rheumatoid arthritis 6 trialsAll Rheumatoid arthritis trials
- Obesity 6 trialsAll Obesity trials
- Coronary artery disease 6 trialsAll Coronary artery disease trials
- Acute myeloid leukemia (aml) 6 trialsAll Acute myeloid leukemia (aml) trials
- Hypertension 6 trialsAll Hypertension trials
- Lymphoma 5 trialsAll Lymphoma trials
- Leukemia 5 trialsAll Leukemia trials
- Type 2 diabetes mellitus 5 trialsAll Type 2 diabetes mellitus trials
- All Non-squamous non-small cell lung cancer trials
- Immunoglobulin a nephropathy 4 trialsAll Immunoglobulin a nephropathy trials
- Diabetes mellitus 4 trialsAll Diabetes mellitus trials
- Overweight 3 trialsAll Overweight trials